Identification of capsazepine as a novel inhibitor of system x_c⁻ and cancer-induced bone pain

References

• AbdelazizDMStoneLSKomarovaSVOsteolysis and pain due to experimental bone metastases are improved by treatment with rapamy-cinBreast Cancer Res Treat2014143222723724327332
   PubMed Web of Science ®Google Scholar
• Jimenez-AndradeJMMantyhWGBloomAPFerngASGeffreCPMantyhPWBone cancer painAnn N Y Acad Sci2010119817318120536932
   PubMed Web of Science ®Google Scholar
• GuiseTAKozlowWMHeras-HerzigAPadaleckiSSYinJJChirgwinJMMolecular mechanisms of breast cancer metastases to boneClin Breast Cancer20055Suppl (2)S46S5315807924
   PubMedGoogle Scholar
• Lozano-OndouaANSymons-LiguoriAMVanderahTWCancer-induced bone pain: mechanisms and modelsNeurosci Lett2013557Pt A525924076008
   PubMed Web of Science ®Google Scholar
• SchmidtBLThe neurobiology of cancer painNeurosci2014205546562
   Google Scholar
• SeidlitzEPSharmaMKSaikaliZGhertMSinghGCancer cell lines release glutamate into the extracellular environmentClin Exp Metastasis200926778178719526315
   PubMed Web of Science ®Google Scholar
• UngardRGSeidlitzEPSinghGInhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone painPain20141551283623999057
   PubMed Web of Science ®Google Scholar
• PortenoyRKTreatment of cancer painLancet201137797842236224721704873
   PubMed Web of Science ®Google Scholar
• SabinoMAMantyhPWPathophysiology of bone cancer painJ Support Oncol200531152415724942
   PubMedGoogle Scholar
• WilsonJStackCHesterJRecent advances in cancer pain managementF1000Prime Rep201461024592322
   PubMedGoogle Scholar
• SharmaMKSeidlitzEPSinghGCancer cells release glutamate via the cystine/glutamate antiporterBiochem Biophys Res Commun20103911919519896463
   PubMed Web of Science ®Google Scholar
• BandaMSpeyerCLSemmaSNMetabotropic glutamate receptor-1 contributes to progression in triple negative breast cancerPLoS One201491e8112624404125
   PubMed Web of Science ®Google Scholar
• TimmermanLAHoltonTYunevaMGlutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic targetCancer Cell201324445046524094812
   PubMed Web of Science ®Google Scholar
• ChillarónJRocaRValenciaAZorzanoAPalacínMHeteromeric amino acid transporters: biochemistry, genetics, and physiologyAm J Physiol Renal Physiol20012816F995F101811704550
   PubMed Web of Science ®Google Scholar
• SatoHTambaMIshiiTBannaiSCloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteinsJ Biol Chem199927417114551145810206947
   PubMed Web of Science ®Google Scholar
• BrakspearKSMasonDJGlutamate signaling in boneFront Endocrinol (Lausanne)201239722888325
   PubMedGoogle Scholar
• CowanRWSeidlitzEPSinghGGlutamate signaling in healthy and diseased boneFront Endocrinol (Lausanne)201238922833735
   PubMedGoogle Scholar
• SloskyLMBassiriRadNMSymonsAMThe cystine/glutamate antiporter system xc− drives breast tumor cell glutamate release and cancer-induced bone painPain2016157112605261627482630
   PubMed Web of Science ®Google Scholar
• DoxseeDWGoutPWKuritaTSulfasalazine-induced cystine starvation: potential use for prostate cancer therapyProstate200767216217117075799
   PubMed Web of Science ®Google Scholar
• GoutPWBuckleyARSimmsCRBruchovskyNSulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)− cystine transporter: a new action for an old drugLeukemia200115101633164011587223
   PubMed Web of Science ®Google Scholar
• FazzariJLinHMurphyCUngardRSinghGInhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-painSci Rep20155838025670024
   PubMed Web of Science ®Google Scholar
• BevanSHothiSHughesGCapsazepine: a competitive antagonist of the sensory neurone excitant capsaicinBr J Pharmacol199210725445521422598
   PubMed Web of Science ®Google Scholar
• TengHPHuangCJYehJHCapsazepine elevates intracellular Ca2+ in human osteosarcoma cells, questioning its selectivity as a vanilloid receptor antagonistLife Sci200475212515252615363657
   PubMed Web of Science ®Google Scholar
• DochertyRJYeatsJCPiperASCapsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in cultureBr J Pharmacol19971217146114679257928
   PubMed Web of Science ®Google Scholar
• GillCHRandallABatesSACharacterization of the human HCN1 channel and its inhibition by capsazepineBr J Pharmacol2004143341142115351778
   PubMed Web of Science ®Google Scholar
• LiuLSimonSACapsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal gangliaNeurosci Lett1997228129329197280
   PubMed Web of Science ®Google Scholar
• van KuppeveldFJJohanssonKEGalamaJMKissingJBölskeGvan der LogtJTMelchersWJDetection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCRAppl Environ Microbiol19946011491527509584
   PubMed Web of Science ®Google Scholar
• BridgesCCKekudaRWangHStructure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cellsInvest Ophthalmol Vis Sci2001421475411133847
   PubMed Web of Science ®Google Scholar
• YeZCSontheimerHGlioma cells release excitotoxic concentrations of glutamateCancer Res199959174383439110485487
   PubMed Web of Science ®Google Scholar
• MenéndezLJuárezLGarcíaEGarcía-SuárezOHidalgoABaa-mondeAAnalgesic effects of capsazepine and resiniferatoxin on bone cancer pain in miceNeurosci Lett20063931707316243435
   PubMed Web of Science ®Google Scholar
• ColemanREClinical features of metastatic bone disease and risk of skeletal morbidityClin Cancer Res20061220 Pt 26243s6249s17062708
   PubMed Web of Science ®Google Scholar
• BrandtMRBeyerCEStahlSMTRPV1 antagonists and chronic pain: beyond thermal perceptionPharmaceuticals (Basel)20125211413224288084
   PubMedGoogle Scholar
• FischMJLeeJWWeissMProspective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancerJ Clin Oncol201230161980198822508819
   PubMed Web of Science ®Google Scholar
• BannaiSExchange of cystine and glutamate across plasma membrane of human fibroblastsJ Biol Chem19862615225622632868011
   PubMed Web of Science ®Google Scholar
• IshiiTSugitaYBannaiSRegulation of glutathione levels in mouse spleen lymphocytes by transport of cysteineJ Cell Physiol198713323303363680392
   PubMed Web of Science ®Google Scholar
• GuedonJMLongoGMajutaLAThomsponMLFealkMNMantyhPWDissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer painPain201615761239124727186713
   PubMed Web of Science ®Google Scholar
• CaterinaMJLefflerAMalmbergABImpaired nociception and pain sensation in mice lacking the capsaicin receptorScience2000288546430631310764638
   PubMed Web of Science ®Google Scholar
• DomercqMSánchez-GómezMVSherwinCEtxebarriaEFernRMatuteCSystem xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytesJ Immunol2007178106549655617475885
   PubMed Web of Science ®Google Scholar
• ChristophTBahrenbergGDe VryJInvestigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout miceMol Cell Neurosci200837357958918249134
   PubMed Web of Science ®Google Scholar
• WalkerKMUrbanLMedhurstSJThe VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic painJ Pharmacol Exp Ther20033041566212490575
   PubMed Web of Science ®Google Scholar
• RamiHKThompsonMWymanPDiscovery of small molecule antagonists of TRPV1Bioorg Med Chem Lett200414143631363415203132
   PubMed Web of Science ®Google Scholar